ADHD

International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder

Citation
Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens A, S, A, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle C, L, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone S, V, Franck J, González R, A, Grau-López L, Groenman A, P, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan J, G, Kaye S, S, Kiefer F, Konstenius M, Levin F, R, Luderer M, Martinotti G, Matthys F, I, A, Meszaros G, Moggi F, Munasur-Naidoo A, P, Post M, Rabinovitz S, Ramos-Quiroga J, A, Sala R, Shafi A, Slobodin O, Staal W, G, Thomasius R, Truter I, van Kernebeek M, W, Velez-Pastrana M, C, Vollstädt-Klein S, Vorspan F, Young J, T, Yule A, van den Brink W, Hendriks V: International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. Eur Addict Res 2020;26:223-232. doi: 10.1159/000508385
Publication Date

This international consensus statement can be used by clinicians and patients together in a shared decision-making process to select the best interventions and to reach optimal outcomes in adolescent patients with concurrent ADHD and SUD.

Non-Medicinal Ritalin Use: Study Enhanced, But Taking a Chance

Publication Date

New research published in the Journal of Neural Transmission highlights a number of potential adverse side-effects from using the stimulant drug Ritalin without a prescription. Ritalin (Methylphenidate) is medically used to treat Attention Deficient Hyper-Activity Disorder (ADHD). However, we also know that the drug is being increasingly used by students to aid concentration.